John Irvin is Director at ExOne Co (XONE). They have made 13 open-market trades across 2 companies since 2007, most recently 2021-11-12.
CIK 0001250606
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $111K since 2007, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XONE | SELL | 2020-11-25 | 2020-11-30 | $12.16 | $243K | -5.4% | -22.6% | +237.1% |
| XONE | SELL | 2020-11-19 | 2020-11-20 | $10.86 | $271K | +6.3% | +6.1% | +260.6% |
| XONE | SELL | 2020-11-10 | 2020-11-12 | $10.77 | $135K | +1.6% | +10.0% | +410.1% |
| XONE | SELL | 2020-10-01 | 2020-10-02 | $12.05 | $301K | +10.4% | -19.7% | -19.8% |
| XONE | BUY | 2020-03-17 | 2020-03-18 | $4.03 | $20K | +40.8% | +34.8% | +100.9% |
| XONE | SELL | 2018-11-16 | 2018-11-20 | $9.73 | $28K | -8.9% | -24.9% | +27.9% |
| XONE | SELL | 2018-01-19 | 2018-01-23 | $10.02 | $164K | -11.8% | -17.5% | -25.3% |
| XONE | SELL | 2018-01-11 | 2018-01-16 | $10.02 | $117K | +6.6% | -14.2% | -22.8% |
| XONE | SELL · 10b5-1 | 2017-11-28 | 2017-11-29 | $12.03 | $24K | -16.8% | -32.8% | -32.6% |
| XONE | SELL | 2017-11-24 | 2017-11-28 | $11.87 | $138K | -9.9% | -29.1% | -30.2% |
| XONE | SELL | 2017-11-20 | 2017-11-28 | $11.66 | $134K | -9.9% | -29.1% | -30.2% |
| XONE | SELL | 2016-10-03 | 2016-10-05 | $15.51 | $78K | -16.0% | -33.9% | -37.2% |
| XONE | SELL | 2013-09-09 | 2013-09-11 | $59.06 | $3.5M | -20.0% | +7.3% | +7.3% |
| STST | BUY | 2007-09-04 | 2007-09-07 | $18.23 | $91K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.